Karyopharm Therapeutics Inc. (KPTI) SEC Filings — 2025
15 SEC filings for Karyopharm Therapeutics Inc. (KPTI) in 2025.
Filings
- Karyopharm's Net Loss Widens Amid Liquidity Concerns — 10-Q · Nov 3, 2025
- Karyopharm Therapeutics Enters Material Definitive Agreement — 8-K · Oct 14, 2025
- Karyopharm Therapeutics Files 8-K with Material Agreements & Financial Updates — 8-K · Oct 8, 2025
- Karyopharm Therapeutics Announces Executive and Board Changes — 8-K · Sep 11, 2025
- Karyopharm Q2 Revenue Dips, Net Loss Narrows Amid Cost Cuts — 10-Q · Aug 11, 2025
- Karyopharm Therapeutics Files 8-K — 8-K · Jul 11, 2025
- Karyopharm Therapeutics Reports Officer/Director Changes & Shareholder Votes — 8-K · May 29, 2025
- Karyopharm Therapeutics Files Q1 2025 10-Q — 10-Q · May 12, 2025
- Karyopharm Therapeutics Inc. DEF 14A Filing — DEF 14A · Apr 14, 2025
- Karyopharm Therapeutics Files 8-K — 8-K · Feb 24, 2025
- Karyopharm Therapeutics Files 8-K on Financials — 8-K · Feb 19, 2025
- Karyopharm Therapeutics Announces Board and Executive Changes — 8-K · Jan 31, 2025
- Karyopharm Therapeutics Files 8-K on Security Holder Vote — 8-K · Jan 30, 2025
- Karyopharm Therapeutics Files 8-K on Financials — 8-K · Jan 13, 2025
- Karyopharm Appoints Dr. Kolitz as Chief Medical Officer — 8-K · Jan 2, 2025